Loading...
Market
Will China's adoption of Ozempic reduce the prevalence of extreme obesity by end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official health statistics and reports from China's National Health Commission
Story
China Adopts Ozempic in Weight Loss Guidelines, British Heart Foundation Optimistic
Sep 3, 2024, 06:04 AM
New guidelines from a leading medical advisory body in China are incorporating 'miracle cure' medications such as Ozempic into weight loss treatments, potentially changing the lives of millions and boosting sales for drugmakers. Bryan Williams from the British Heart Foundation expressed optimism about Ozempic's potential to help with extreme weight loss and other conditions. Ozempic, originally developed to treat diabetes, has shown promise in aiding weight loss and reducing risks of cardiovascular issues. Recent studies indicate that semaglutide, the active ingredient in Ozempic, is effective in reducing the progression from prediabetes to type 2 diabetes. Despite the enthusiasm, experts urge caution, noting the need for long-term studies to fully understand the drug's effects. Additionally, new research has found no increased risk of mental health issues among users of semaglutide for weight loss.
View original story
Similar markets
Price competitiveness • 25%
Efficacy and safety profile • 25%
Marketing and distribution • 25%
Regulatory support • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
< 1 million • 33%
1 - 2 million • 33%
> 2 million • 34%
Mostly positive • 25%
Mixed • 25%
Mostly negative • 25%
No significant change • 25%
Increased Sales • 25%
Decreased Sales • 25%
No Significant Change • 25%
Product Recall • 25%
Anti-ageing • 25%
Weight loss • 25%
Heart disease reduction • 25%
Other • 25%
Increase by more than 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
Decrease or no change • 25%
